Indication
Giant cell arteritis
Giant cell arteritis is a chronic, systemic granulomatous vasculitis that primarily targets medium- and large-sized arteries, notably the aorta and the extracranial branches of the carotid arteries. Read more about Giant cell arteritis
152 drugs 105 manufacturers
Drugs that treat it
Common Giant cell arteritis therapies.
RINVOQ (upadacitinib)
DEXABLISS (dexamethasone)
ZCORT (dexamethasone)
MILLIPRED (prednisolone)
DOUBLEDEX (PF) (dexamethasone sodium phosphate/PF)
ACTIVE INJECTION KIT D (PF) (dexamethasone sodium phosphate/PF)
MAS CARE-PAK (PF) (dexamethasone sodium phosphate/PF)
TRIESENCE (PF) (triamcinolone acetonide/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGiant cell arteritis is a chronic, systemic granulomatous vasculitis that primarily targets medium- and large-sized arteries, notably the aorta and the extracranial branches of the carotid arteries.
The condition occurs almost exclusively in adults aged 50 and older, with peak incidence between 70 and 80 years of age and a higher prevalence in women.
Pathophysiologically, transmural vascular inflammation, fragmentation of the internal elastic lamina, and intimal hyperplasia cause luminal narrowing, frequently manifesting as temporal headaches, jaw claudication, scalp tenderness, systemic inflammation, and ischemic complications such as irreversible vision loss.
- nih.gov
Giant cell arteritis is a chronic, systemic granulomatous vasculitis that primarily targets medium- and large-sized arteries, notably the aorta and the extracranial branches of the carotid arteries Pathophysiologically, transmural vascular inflammation, fragmentation of the internal elastic lamina, and intimal hyperplasia cause luminal narrowing, frequently manifesting as temporal headaches, jaw claudication, scalp tenderness, systemic inflammation, and ischemic complications such as irreversibl...
- merckmanuals.com
Giant cell arteritis is a chronic, systemic granulomatous vasculitis that primarily targets medium- and large-sized arteries, notably the aorta and the extracranial branches of the carotid arteries The condition occurs almost exclusively in adults aged 50 and older, with peak incidence between 70 and 80 years of age and a higher prevalence in women Pathophysiologically, transmural vascular inflammation, fragmentation of the internal elastic lamina, and intimal hyperplasia cause luminal narrowing...
- mayoclinic.org
Pathophysiologically, transmural vascular inflammation, fragmentation of the internal elastic lamina, and intimal hyperplasia cause luminal narrowing, frequently manifesting as temporal headaches, jaw claudication, scalp tenderness, systemic inflammation, and ischemic complications such as irreversible vision loss
Personalize your experience
Follow Giant cell arteritis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.